SCHEMBL4293948

SCHEMBL4293948

CN(C)CCNC(=O)c1cccc(-c2c[nH]c(=O)c3c2ccc2ccc(Cl)cc23)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.47
MAPK10 P53779 1/20 0.47
MAPK14 Q16539 1/20 0.47
PARP1 P09874 2/20 0.44
FYN P06241 1/20 0.44
PRKD3 O94806 1/20 0.44
PRKD1 Q15139 1/20 0.44
PRKD2 Q9BZL6 1/20 0.44
CHEK1 O14757 1/20 0.43
PDE1A P54750 1/20 0.43
PDE1B Q01064 1/20 0.43
PDE4D Q08499 1/20 0.43
PDE7A Q13946 1/20 0.43
PDE1C Q14123 1/20 0.43
HAT1 O14929 2/20 0.43
EP300 Q09472 2/20 0.43
MAPT P10636 1/20 0.43
SNCA P37840 1/20 0.43
HRH4 Q9H3N8 2/20 0.42
HRH3 Q9Y5N1 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4291922 0.91 HPGD (0.45) MAPK8MAPK10MAPK14FYNCHEK1
SCHEMBL13662615 0.90 FYN (0.44) MAPK8MAPK10MAPK14PARP1FYN
SCHEMBL4553565 0.89 MAPT (0.41) MAPK8MAPK10MAPK14PARP1FYN
SCHEMBL4287646 0.80 SERPINE1 (0.45) PARP1CHEK1MAP4K4
SCHEMBL4294755 0.79 CHEK1 (0.44) MAPK8PARP1FYNPRKD3PRKD2
SCHEMBL4287632 0.76 CHEK1 (0.45) MAPK8PARP1CHEK1
SCHEMBL4295944 0.76 SMN1; SMN2 (0.45) MAPK10CHEK1MAPTKMT2AIGF1R
SCHEMBL13662591 0.76 RAB9A (0.45) PARP1MAPTKMT2AIGF1R
SCHEMBL17155484 0.75 PRKD3 (0.48) MAPK8MAPK10MAPK14PRKD3PRKD1
SCHEMBL4287635 0.74 PARP1 (0.55) PARP1CHEK1KMT2AMAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US claimed
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
WO-2007008502-A2 INHIBITORS OF CHECKPOINT KINASES MERCK & CO., INC. (US) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258852-A1 Inhibitors of Checkpoint Kinases CHEK1, CHEK2, CDKN1A MAPK8 877/4885MAPK10 1069/4885MAPK14 1070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.